Your browser doesn't support javascript.
loading
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
Usman, Muhammad Shariq; Siddiqi, Tariq Jamal; Anker, Stefan D; Bakris, George L; Bhatt, Deepak L; Filippatos, Gerasimos; Fonarow, Gregg C; Greene, Stephen J; Januzzi, James L; Khan, Muhammad Shahzeb; Kosiborod, Mikhail N; McGuire, Darren K; Piña, Ileana L; Rosenstock, Julio; Vaduganathan, Muthiah; Verma, Subodh; Zieroth, Shelley; Butler, Javed.
Afiliación
  • Usman MS; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Siddiqi TJ; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Anker SD; Department of Cardiology (CVK) of German Heart Center Charité; Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany; Institute of Heart Diseases, Wroclaw Medical University, Wr
  • Bakris GL; Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.
  • Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA.
  • Filippatos G; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Fonarow GC; Division of Cardiology, University of California Los Angeles, Los Angeles, California, USA.
  • Greene SJ; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Januzzi JL; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA.
  • Khan MS; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri, USA.
  • McGuire DK; Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA; Parkland Health and Hospital System, Dallas, Texas, USA.
  • Piña IL; Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Rosenstock J; Velocity Clinical Research at Medical City, Dallas, Texas, USA.
  • Vaduganathan M; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA.
  • Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Departments of Surgery and Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Zieroth S; Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA; Baylor Scott and White Research Institute, Baylor Scott and White Health, Dallas, Texas, USA. Electronic address: butlzih@gmail.com.
J Am Coll Cardiol ; 81(25): 2377-2387, 2023 06 27.
Article en En | MEDLINE | ID: mdl-37344038

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos